Business
Aptar designs and makes dosing, dispensing, sealing, and protection technologies for pharma, beauty, food, beverage, personal care, and home care markets.
Aptar revenue rose 5.4% to $3.8B and profit improved, but cash flow softened as debt and buybacks stepped up.
The read at a glance✓ Audited against SEC data
- Business mix — Pharma, Beauty, and Closures platformsNote
- Revenue — Revenue rose 5.4%OK
- Profit — Net income rose 4.9%OK
- Cash — FCF fell 18.4%Watch
- Capital — Debt and buybacks increasedWatch
- Insiders — 0 buys / 6 sellsWatch
- Accounting — Altman-Z grey; other screens unavailableWatch
Where the revenue comes from
Fiscal 2025, as APTARGROUP, INC. reports it. History and quarterly detail are in the app.
- Pharma$1.7B
- Beauty$1.3B
- Closures$736.9M
Leadership changes
From APTARGROUP, INC.'s own filings, the day they're filed.
- Gael Touya · President · appointmenteff. 2026-09-01
- Aditya J. Gandhi · President · appointmenteff. 2026-06-08
- Vanessa Kanu · President · appointmenteff. 2025-01-01
Latest filings
- 8-K · Company announcement2026-09-01
- 10-Q · Quarterly report2026-07-31
- 8-K · Company announcement2026-07-30
- 8-K · Company announcement2026-05-13
- 8-K · Company announcement2026-05-07
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about APTARGROUP, INC., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.